Metbleo Injection
By Metbleo
Rx
1 Injection in a Vial

Composition
Bleomycin(15IU)

Manufacturer - Metta Life Sciences Private Limited
G-040 Vikas Centre,106, S.V. Road, Santacruz West Mumbai City Mh 400054 India

Expires on or after
September, 2025

liver
Metbleo Injection is considered safe for patients with liver disease based on the available data. There is limited information indicating that adjusting the dose of Metbleo Injection may not be necessary in individuals with liver issues. It is essential to consult your doctor, especially if you have a history or any signs of liver-related diseases, before using Bleomycin Injection. Your healthcare provider will carefully assess the benefits and potential risks before recommending this medication.

kidney
Caution should be taken when using Metbleo Injection in patients with kidney disease, as dose adjustment may be necessary. If you have a history of kidney-related issues, consult your doctor for evaluation of benefits and risks before using this medication.

alcohol
It is advised to avoid alcohol while using Metbleo Injection to prevent potential side effects. Consult your doctor for more information.

driving
It's important to be cautious when driving after taking Metbleo Injection as it may lead to tiredness or weakness, affecting your ability to drive safely. Side effects like nausea and vomiting can impact reactions, so avoid driving if affected.

pregnancy
Metbleo Injection is not safe to use during pregnancy because it can harm the developing baby. In rare cases of life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Effective contraception is necessary for both men and women using this medication. It is important to talk to your doctor about any concerns.

breastfeeding
"Caution Metbleo Injection is not recommended for breastfeeding mothers as it may pass into breastmilk and harm the baby. It is contraindicated during breastfeeding."
Habit Forming | No |
Chemical Class | Antitumor Antibiotics |
Therapeutic Class | - |
Action Class | Alkaloids-cytotoxic agents |
₹650
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024